Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Pazopanib demonstrates activity in patients with germ cell tumors

Feb. 4, 2014

Evidence of activity seen with MPX in phase I prostate cancer study

Feb. 3, 2014

Radiotracer [18F]VM-4-037 evaluated in phase II renal cancer study

Feb. 3, 2014

Multiple pivotal phase III trials under way at Array BioPharma

Jan. 31, 2014

Clovis Oncology plans big year for 2014

Jan. 31, 2014

Gilead Sciences details outlook for 2014

Jan. 30, 2014

Morphosys provides overview of development pipeline

Jan. 30, 2014

GERD linked to FOXF1 and MHC locus gene polymorphisms

Jan. 29, 2014

DENND2D identified as a biomarker of esophageal cancer prognosis

Jan. 28, 2014

MAGED4 associated with progression of squamous cell carcinoma of the esophagus

Jan. 28, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
Neuracle eyes Shanghai IPO as global BCI funding surges
BioWorld
Neuracle Medical Technology Co. Ltd. is seeking a Shanghai IPO that could make it China’s first publicly listed invasive brain-computer interface (BCI) company,...